Importance of age in chronic hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 4, Issue 4, 1997, Pages 255-264

  Wong, V ^a   Caronia, S ^b   Wight, D ^c   Palmer, C R ^d   Petrik, J ^a   Britton, P ^a   Alexander, G J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b School of Specialisation in Gastroenterology Hepatology and Digestive Endoscopy   (Italy)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Age; Fibrosis; Hepatitis C

Indexed keywords

HEPATITIS ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BIOPSY; BLOOD; CHRONIC DISEASE; DISEASE COURSE; ECHOGRAPHY; ENZYMOLOGY; FEMALE; HEPATITIS C; HUMAN; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOPSY; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HEPATITIS ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 0031180736     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00054.x     Document Type: Article

References (28)

1. Di Bisceglie A, Goodman Z, Ishak K, Hoofnagle J, Melipolder J, Alter H. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-974.
2. Tremolada F, Casarin C, Alberti A et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis C. J Hepatol 1992; 16: 273-281.
3. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-243.
4. Wreghitt TG, Gray JJ, Allain J-P et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 1994; 20: 768-772.
5. Sirchia G, Bellobuono A, Giovanetti A, Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet 1989; ii: 797.
6. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993; 34: S13-S16.
7. Davis GL, Balart LA, Schiff ER et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 1989; 321: 1501-1506.
8. Di Bisceglie AM, Martin P, Kassianides C et al. Recombinant interferon-alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-1510.
9. Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol 1991; 13: 192-199.
10. Camps J, Garcia N, Riezuboj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alpha interferon. J Hepatol 1993; 19: 408-412.
11. Castillo I, Bartolome J, Navas S, Gonzalez S, Herrero M, Carreno V. Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon. Hepatology 1994; 19: 1342-1346.
12. Makris M, Preston FE, Triger DR et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335: 1117-1119.
13. Alberti A, Morsica G, Cavalletto D, Noventa F, Pontisso PAR. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697-698.
14. Merican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Quart J Med 1993; 86: 119-125.
15. Irving WL, Neal KR. Underwood JCE et al. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Br Med J 1994; 308: 695-696.
16. Bruno S, Rossi S, Petroni ML, Villa E, Zuin M, Podda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. Br Med J 1994; 308: 697-698.
17. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
18. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
19. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford, UK: Blackwell Scientific, 1987.
20. Everitt BS. The Analysis of Contingency Tables, 2nd edn. London: Chapman and Hall, 1992.
21. Gilmore I, Burroughs A, Murray-Lyon I, Williams R, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36: 437-441.
22. Hiramatsu N, Hayashi N, Kasahara A et al. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. J Hepatol 1995; 22: 135-142.
23. Van der Poel CL, Cuypers HTM, Reesink HW et al. Confirmation of hepatitis C virus infection by four antigen recombinant immunoblot assay. Lancet 1991; 337: 317-319.
24. Bassetti D, Cutrupi V, Dallago B, Alfonsi P. Second generation RIBA to confirm diagnosis of hepatitis C virus infection. Lancet 1991; 337: 912-913.
25. Nishiguchi S, Kuroki T, Yabusako T et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 1991; 14: 985-989.
26. Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R. Serum hyaluronan as marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 1995; 22: 22-26.
27. Mendenhall C, Seeff L, Diehl A et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology 1991; 14: 581-589.
28. Beukers R, van Zanten RAA, Schalm SW. Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis. J Hepatol 1992; 14: 22-29.